Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen

Katherine L Cook1, Ayesha N Shajahan, Anni Wärri

  • 1Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20057, USA.

Cancer Research
|July 4, 2012
PubMed

Insights

Glucose-regulated protein 78 (GRP78) overexpression drives endocrine therapy resistance in estrogen receptor-positive (ER+) breast cancer by inhibiting apoptosis and promoting autophagy. Reducing GRP78 restores sensitivity to antiestrogen treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Estrogen receptor-positive (ER+) breast cancer, comprising over 70% of cases, often develops resistance to endocrine therapies.
  • The molecular mechanisms underlying this treatment resistance are not fully understood.
  • Glucose-regulated protein 78 (GRP78) is investigated for its potential role in mediating this resistance.

Purpose of the Study:

  • To investigate the role of glucose-regulated protein 78 (GRP78) in acquired antiestrogen resistance in ER+ breast cancer.
  • To elucidate the molecular mechanisms by which GRP78 mediates endocrine resistance.
  • To explore therapeutic strategies targeting GRP78 to overcome treatment resistance.

Main Methods:

  • Analysis of GRP78 expression in human breast tumors and cell lines.
  • Gene knockdown and overexpression experiments to assess GRP78's effect on antiestrogen sensitivity.
  • Investigation of cellular signaling pathways, including apoptosis and autophagy, in response to GRP78 modulation.
  • Pharmacological inhibition of autophagy and caspase pathways.

Main Results:

  • GRP78 expression was increased in ER+ antiestrogen-resistant cells and tumors with acquired resistance, but not in de novo resistance.
  • Knockdown of GRP78 restored antiestrogen sensitivity, while its overexpression induced resistance.
  • GRP78 integrated signaling pathways to inhibit apoptosis and promote prosurvival autophagy via TSC2/AMPK-mediated mTOR inhibition.
  • Inhibition of autophagy or combined knockdown of GRP78 and beclin-1 synergistically restored sensitivity.

Conclusions:

  • GRP78 plays a critical role in mediating acquired endocrine resistance in ER+ breast cancer.
  • GRP78 influences cell fate by integrating pathways like the unfolded protein response, apoptosis, and autophagy.
  • Targeting GRP78 and/or autophagy presents a potential strategy to overcome antiestrogen resistance.

Related Concept Videos

Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...